Trials / Completed
CompletedNCT02487381
Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids
Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids on the Endocannabinoid System, Cognition and Neuronal Oscillations
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Central Institute of Mental Health, Mannheim · Academic / Other
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The study evaluates the gene-environment interaction of the COMT-genotype on the effects of the phytocannabinoids delta-9-tetrahydrocannabinol, cannabidiol or a combination of both on induction of psychotic symptoms, endocannabinoid levels in human body fluids, neuronal processing, and neural oscillations. In addition the effects of the phytocannabinoids on lipid levels in serum and cerebrospinal fluid, cognition, neural synchrony and neuronal processing assessed by EEG and fMRI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | delta-9-tetrahydrocannabinol | |
| DRUG | Cannabidiol | |
| DRUG | Placebo |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2015-07-01
- Completion
- 2015-08-01
- First posted
- 2015-07-01
- Last updated
- 2015-08-17
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02487381. Inclusion in this directory is not an endorsement.